Lv64
2860 积分 2022-11-10 加入
The evolving regulatory landscape in regenerative medicine
5天前
已完结
Comparison of Clinical Evidence Submitted to the FDA and EMA for Cell and Gene Therapies
5天前
已完结
Post-marketing surveillance framework of cell and gene therapy products in the European Union, the United States, Japan, South Korea and China: a comparative study
5天前
已完结
The evolving regulatory landscape in regenerative medicine
5天前
已完结
Regulatory oversight of cell therapy in China: Government’s efforts in patient access and therapeutic innovation
5天前
已完结
Cell and Gene Therapy Product Approvals in China: Insights into Clinical Trials and Regulatory Advances
5天前
已完结
From fiction to science: clinical potentials and regulatory considerations of gene editing
5天前
已完结
Regional empowerment through decentralised governance under a centralised regulatory system facilitates the development of cellular therapy in China
5天前
已完结
How to democratize cell and gene therapy: A global approach
5天前
已完结
Development and Regulation of Gene and Cell-Based Therapies in Europe: A Quantification and Reflection
5天前
已完结
皖公网安备34019202002308
